Hailat, M.; Zakaraya, Z.; Al-Ani, I.; Meanazel, O.A.; Al-Shdefat, R.; Anwer, M.K.; Saadh, M.J.; Abu Dayyih, W.
Pharmacokinetics and Bioequivalence of Two Empagliflozin, with Evaluation in Healthy Jordanian Subjects under Fasting and Fed Conditions. Pharmaceuticals 2022, 15, 193.
https://doi.org/10.3390/ph15020193
AMA Style
Hailat M, Zakaraya Z, Al-Ani I, Meanazel OA, Al-Shdefat R, Anwer MK, Saadh MJ, Abu Dayyih W.
Pharmacokinetics and Bioequivalence of Two Empagliflozin, with Evaluation in Healthy Jordanian Subjects under Fasting and Fed Conditions. Pharmaceuticals. 2022; 15(2):193.
https://doi.org/10.3390/ph15020193
Chicago/Turabian Style
Hailat, Mohammad, Zainab Zakaraya, Israa Al-Ani, Osaid Al Meanazel, Ramadan Al-Shdefat, Md. Khalid Anwer, Mohamed J. Saadh, and Wael Abu Dayyih.
2022. "Pharmacokinetics and Bioequivalence of Two Empagliflozin, with Evaluation in Healthy Jordanian Subjects under Fasting and Fed Conditions" Pharmaceuticals 15, no. 2: 193.
https://doi.org/10.3390/ph15020193
APA Style
Hailat, M., Zakaraya, Z., Al-Ani, I., Meanazel, O. A., Al-Shdefat, R., Anwer, M. K., Saadh, M. J., & Abu Dayyih, W.
(2022). Pharmacokinetics and Bioequivalence of Two Empagliflozin, with Evaluation in Healthy Jordanian Subjects under Fasting and Fed Conditions. Pharmaceuticals, 15(2), 193.
https://doi.org/10.3390/ph15020193